A Phase 1 clinical study of AZD4635 in patients with advanced solid malignancies

Trial Identifier: D8730C00001
Sponsor: AstraZeneca
NCTID:: NCT02740985
Start Date: June 2016
Primary Completion Date: December 2020
Study Completion Date: March 2023
Condition: Cancer - Other; Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Spanish Translation

Trial Locations

Country Location
US, AR Fayetteville, AR, US, 72703
US, CA Fresno, CA, US, 93720
US, CO Denver, CO, US, 80218
US, CT New Haven, CT, US, 06519
US, FL Daytona Beach, FL, US, 32117
US, FL Lecanto, FL, US, 34461
US, FL North Port, FL, US, 34288
US, FL Sarasota, FL, US, 34232
US, IL Decatur, IL, US, 62526
US, NC Durham, NC, US, 27710
US, NV Las Vegas, NV, US, 89119
US, NY New York, NY, US, 10032
US, OK Oklahoma City, OK, US, 73104
US, PA Philadelphia, PA, US, 19107
US, SC Myrtle Beach, SC, US, 29572
US, TN Chattanooga, TN, US, 37404
US, TN Nashville, TN, US, 37203